Resection of brain metastases previously treated with stereotactic radiosurgery

Giacomo G. Vecil, Dima Suki, Marcos V C Maldaun, Frederick F. Lang, Raymond Sawaya

Research output: Contribution to journalArticle

45 Citations (Scopus)

Abstract

Object. To date, no report has been published on outcomes of patients undergoing resection for brain metastases who were previously treated with stereotactic radiosurgery (SRS). Consequently, the authors reviewed their institutional experience with this clinical scenario to assess the efficacy of surgical intervention. Methods. Sixty-one patients (each harboring three or fewer brain lesions), who were treated at a single institution between June 1993 and August 2002 were identified. Patient charts and their neuroimaging and pathological reports were retrospectively reviewed to determine overall survival rates, surgical complications, and recurrence rates. A univariate analysis revealed that patient preoperative recursive partitioning analysis (RPA) classification, primary disease status, preoperative Karnofsky Performance Scale score, type of focal treatment undergone for nonindex lesions, and major postoperative surgical complications were factors that significantly affected survival (p ≤ 0.05). In contrast, only the RPA class and focal (conventional surgery or SRS) treatment of nonindex lesions significantly (or nearly significantly) affected survival in the multivariate analysis. Major neurological complications occurred in only 2% of patients. The median time to distant recurrence after resection was 8.4 months; that to local recurrence was not reached. The overall median survival time was 11.1 months, with 25% of patients surviving 2 or more years. Conventional surgery facilitated tapering of steroid administration. Conclusions. The complication, morbidity, survival, and recurrence rates are consistent with those seen after conventional surgery for recurrent brain metastases. Our results indicate that in selected patients with a favorable RPA class in whom nonindex lesions are treated with focal modalities, surgery can provide long-term control of SRS-treated lesions and positively affect overall survival.

Original languageEnglish (US)
Pages (from-to)209-215
Number of pages7
JournalJournal of Neurosurgery
Volume102
Issue number2
DOIs
StatePublished - Feb 2005
Externally publishedYes

Fingerprint

Radiosurgery
Neoplasm Metastasis
Brain
Recurrence
Survival
Survival Rate
Karnofsky Performance Status
Neuroimaging
Multivariate Analysis
Steroids
Morbidity
Therapeutics

Keywords

  • Brain metastases
  • Complication
  • Prognostic factor
  • Radiosurgery
  • Resection

ASJC Scopus subject areas

  • Clinical Neurology
  • Neuroscience(all)

Cite this

Vecil, G. G., Suki, D., Maldaun, M. V. C., Lang, F. F., & Sawaya, R. (2005). Resection of brain metastases previously treated with stereotactic radiosurgery. Journal of Neurosurgery, 102(2), 209-215. https://doi.org/10.3171/jns.2005.102.2.0209

Resection of brain metastases previously treated with stereotactic radiosurgery. / Vecil, Giacomo G.; Suki, Dima; Maldaun, Marcos V C; Lang, Frederick F.; Sawaya, Raymond.

In: Journal of Neurosurgery, Vol. 102, No. 2, 02.2005, p. 209-215.

Research output: Contribution to journalArticle

Vecil, GG, Suki, D, Maldaun, MVC, Lang, FF & Sawaya, R 2005, 'Resection of brain metastases previously treated with stereotactic radiosurgery', Journal of Neurosurgery, vol. 102, no. 2, pp. 209-215. https://doi.org/10.3171/jns.2005.102.2.0209
Vecil, Giacomo G. ; Suki, Dima ; Maldaun, Marcos V C ; Lang, Frederick F. ; Sawaya, Raymond. / Resection of brain metastases previously treated with stereotactic radiosurgery. In: Journal of Neurosurgery. 2005 ; Vol. 102, No. 2. pp. 209-215.
@article{e243aebc34e046668484515f8800101f,
title = "Resection of brain metastases previously treated with stereotactic radiosurgery",
abstract = "Object. To date, no report has been published on outcomes of patients undergoing resection for brain metastases who were previously treated with stereotactic radiosurgery (SRS). Consequently, the authors reviewed their institutional experience with this clinical scenario to assess the efficacy of surgical intervention. Methods. Sixty-one patients (each harboring three or fewer brain lesions), who were treated at a single institution between June 1993 and August 2002 were identified. Patient charts and their neuroimaging and pathological reports were retrospectively reviewed to determine overall survival rates, surgical complications, and recurrence rates. A univariate analysis revealed that patient preoperative recursive partitioning analysis (RPA) classification, primary disease status, preoperative Karnofsky Performance Scale score, type of focal treatment undergone for nonindex lesions, and major postoperative surgical complications were factors that significantly affected survival (p ≤ 0.05). In contrast, only the RPA class and focal (conventional surgery or SRS) treatment of nonindex lesions significantly (or nearly significantly) affected survival in the multivariate analysis. Major neurological complications occurred in only 2{\%} of patients. The median time to distant recurrence after resection was 8.4 months; that to local recurrence was not reached. The overall median survival time was 11.1 months, with 25{\%} of patients surviving 2 or more years. Conventional surgery facilitated tapering of steroid administration. Conclusions. The complication, morbidity, survival, and recurrence rates are consistent with those seen after conventional surgery for recurrent brain metastases. Our results indicate that in selected patients with a favorable RPA class in whom nonindex lesions are treated with focal modalities, surgery can provide long-term control of SRS-treated lesions and positively affect overall survival.",
keywords = "Brain metastases, Complication, Prognostic factor, Radiosurgery, Resection",
author = "Vecil, {Giacomo G.} and Dima Suki and Maldaun, {Marcos V C} and Lang, {Frederick F.} and Raymond Sawaya",
year = "2005",
month = "2",
doi = "10.3171/jns.2005.102.2.0209",
language = "English (US)",
volume = "102",
pages = "209--215",
journal = "Journal of Neurosurgery",
issn = "0022-3085",
publisher = "American Association of Neurological Surgeons",
number = "2",

}

TY - JOUR

T1 - Resection of brain metastases previously treated with stereotactic radiosurgery

AU - Vecil, Giacomo G.

AU - Suki, Dima

AU - Maldaun, Marcos V C

AU - Lang, Frederick F.

AU - Sawaya, Raymond

PY - 2005/2

Y1 - 2005/2

N2 - Object. To date, no report has been published on outcomes of patients undergoing resection for brain metastases who were previously treated with stereotactic radiosurgery (SRS). Consequently, the authors reviewed their institutional experience with this clinical scenario to assess the efficacy of surgical intervention. Methods. Sixty-one patients (each harboring three or fewer brain lesions), who were treated at a single institution between June 1993 and August 2002 were identified. Patient charts and their neuroimaging and pathological reports were retrospectively reviewed to determine overall survival rates, surgical complications, and recurrence rates. A univariate analysis revealed that patient preoperative recursive partitioning analysis (RPA) classification, primary disease status, preoperative Karnofsky Performance Scale score, type of focal treatment undergone for nonindex lesions, and major postoperative surgical complications were factors that significantly affected survival (p ≤ 0.05). In contrast, only the RPA class and focal (conventional surgery or SRS) treatment of nonindex lesions significantly (or nearly significantly) affected survival in the multivariate analysis. Major neurological complications occurred in only 2% of patients. The median time to distant recurrence after resection was 8.4 months; that to local recurrence was not reached. The overall median survival time was 11.1 months, with 25% of patients surviving 2 or more years. Conventional surgery facilitated tapering of steroid administration. Conclusions. The complication, morbidity, survival, and recurrence rates are consistent with those seen after conventional surgery for recurrent brain metastases. Our results indicate that in selected patients with a favorable RPA class in whom nonindex lesions are treated with focal modalities, surgery can provide long-term control of SRS-treated lesions and positively affect overall survival.

AB - Object. To date, no report has been published on outcomes of patients undergoing resection for brain metastases who were previously treated with stereotactic radiosurgery (SRS). Consequently, the authors reviewed their institutional experience with this clinical scenario to assess the efficacy of surgical intervention. Methods. Sixty-one patients (each harboring three or fewer brain lesions), who were treated at a single institution between June 1993 and August 2002 were identified. Patient charts and their neuroimaging and pathological reports were retrospectively reviewed to determine overall survival rates, surgical complications, and recurrence rates. A univariate analysis revealed that patient preoperative recursive partitioning analysis (RPA) classification, primary disease status, preoperative Karnofsky Performance Scale score, type of focal treatment undergone for nonindex lesions, and major postoperative surgical complications were factors that significantly affected survival (p ≤ 0.05). In contrast, only the RPA class and focal (conventional surgery or SRS) treatment of nonindex lesions significantly (or nearly significantly) affected survival in the multivariate analysis. Major neurological complications occurred in only 2% of patients. The median time to distant recurrence after resection was 8.4 months; that to local recurrence was not reached. The overall median survival time was 11.1 months, with 25% of patients surviving 2 or more years. Conventional surgery facilitated tapering of steroid administration. Conclusions. The complication, morbidity, survival, and recurrence rates are consistent with those seen after conventional surgery for recurrent brain metastases. Our results indicate that in selected patients with a favorable RPA class in whom nonindex lesions are treated with focal modalities, surgery can provide long-term control of SRS-treated lesions and positively affect overall survival.

KW - Brain metastases

KW - Complication

KW - Prognostic factor

KW - Radiosurgery

KW - Resection

UR - http://www.scopus.com/inward/record.url?scp=14844286198&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=14844286198&partnerID=8YFLogxK

U2 - 10.3171/jns.2005.102.2.0209

DO - 10.3171/jns.2005.102.2.0209

M3 - Article

C2 - 15739546

AN - SCOPUS:14844286198

VL - 102

SP - 209

EP - 215

JO - Journal of Neurosurgery

JF - Journal of Neurosurgery

SN - 0022-3085

IS - 2

ER -